This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
marijuana: Archive
Marijuana ETFs Bounce Back: Can the Rally Last?
by Sanghamitra Saha
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
TSLAPositive Net Change AAPLNegative Net Change GWPHPositive Net Change IIPRPositive Net Change CGCNegative Net Change APHANegative Net Change TLRYPositive Net Change ACBPositive Net Change CRONNegative Net Change YOLOPositive Net Change CNBSPositive Net Change PNegative Net Change
etfs marijuana
What's in the Cards for OrganiGram (OGI) in Q4 Earnings?
by Zacks Equity Research
According to OrganiGram (OGI), there is hugely unmet consumer demand for CBD products.
GWPHPositive Net Change TLRYPositive Net Change CRONNegative Net Change OGINegative Net Change
earnings marijuana medical
Top & Flop ETFs Halfway Through Q4
by Sweta Killa
The fourth quarter brings strong gains for Wall Street buoyed by easing U.S.-China trade worries, stronger-than-expected corporate earnings and Fed's third rate cut.
IHFNegative Net Change TAPRNo Net Change FTXLNegative Net Change VXXNegative Net Change BIIBPositive Net Change INRNegative Net Change
etfs marijuana medical semiconductor
Why Marijuana Stocks Plummeted in 2019
by Madeleine Johnson
Marijuana stocks were on a tear last year, but 2019 has sent stock tumbling back down to Earth. What happened?
TLRYPositive Net Change ACBPositive Net Change CGCNegative Net Change CRONNegative Net Change
marijuana pot-stocks
Bull of the Day: GW Pharmaceuticals (GWPH)
by Kevin Cook
First FDA-approved cannabis drug is on its way to blockbuster status with triple-digit sales growth
GWPHPositive Net Change
biotechs cannabis marijuana medical
Innovative Industrial Boosts Pennsylvania Base on Asset Buyout
by Zacks Equity Research
Expansion of Pennsylvania portfolio and lease with subsidiary of Green Thumb Industries to help Innovative Industrial (IIPR) bank on the favorable trends as well as drive top-line growth.
CUZNegative Net Change IIPRPositive Net Change DREPositive Net Change PLDNegative Net Change
finance marijuana medical reit
Canopy Growth's Drake Deal Eases Pullback as Q2 Earnings Near
by Christopher Vargas
Canopy Growth (CGC) is set to report its second quarter results before the market opens on Thursday, November 14.
STZPositive Net Change CGCNegative Net Change
earnings marijuana
Trump Trade, Walmart & Nvidia Previews & Buy CASY Stock - Free Lunch
by Benjamin Rains
All eyes will be on President Trump Tuesday for U.S.-China trade war updates. Walmart, Nvidia, and others are set to report their quarterly earnings. And why Casey's General Stores (CASY) is a Zacks Rank #1 (Strong Buy) right now...
CSCOPositive Net Change DISNegative Net Change NFLXNegative Net Change AMZNNegative Net Change AAPLNegative Net Change CASYNegative Net Change WMTPositive Net Change SBUXNegative Net Change NVDAPositive Net Change CGCNegative Net Change CRONNegative Net Change
consumer-discretionary consumer-staples earnings finance marijuana retail tech-stocks
Can European Buyouts Aid Canopy Growth's (CGC) Q2 Earnings?
by Zacks Equity Research
Canopy Growth (CGC) acquires a number of European companies to expand its production base across a region that promises great opportunities.
CGCNegative Net Change
earnings marijuana medical
What's in the Cards for Aurora Cannabis (ACB) in Q1 Earnings?
by Zacks Equity Research
Aurora Cannabis' (ACB) Q1 earnings are likely to reflect cannabis revenue growth and improved gross margin.
BMOPositive Net Change CCLPositive Net Change ACBPositive Net Change CGCNegative Net Change
earnings marijuana